Dr. Anna Popova is a head of biological sub-group in the Multifunctional Materials Systems research laboratory at the Institute of Biological and Chemical Systems (IBCS-FMS) at Karlsruhe Institute of Technology (KIT), Germany led by Prof. Pavel Levkin. She graduated from the department of Cell Biology and Immunology of the Biological Faculty, Lomonosov Moscow State University in Russia and obtained her Ph.D. in Cell and Molecular Biology in at University of Heidelberg, Germany. Since January 2014 Dr. Popova started at KIT as a project leader and head of the biology sub-group. Dr. Popova is the co-founder of Aquarray GmbH. For more information, check out her website here.
• Personalized oncology: developing highly miniaturized protocols and workflows for personalized drug sensitivity and resistance testing of patient-derived cancer cells |
Education and Research Experience
Current position Project Leader |
Co-founder and CTO of Aquarray GmbH | 2018-present |
|
Project Leader Institute of Biological and Chemical Systems- Functional and Molecular Systems (IBSC-FMS), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
|
2014-present |
Ph.D. |
Department of Dermatology and Allergology University Medical Centre Mannheim University of Heidelberg
|
2006-2009 |
Research Assistant |
Institute for Medical Physics and Biophysics University Hospital Charite
|
2006 |
Research Assistant |
Engelhardt Institute of Molecular Biology, Moscow, Russia
|
2005-2006 |
Research Assistant |
Institute for Virus Research Kyoto University
|
2004 |
Research Assistant |
Laboratory of Viral Carcinogenesis Institute for Carcinogenesis Blokhin Cancer Research Center, Moscow, Russia
|
2002- 2005 |
M.Sc. |
Lomonosov Moscow State University Department of Cell Biology and Immunology Microbiology, with excellence |
2000-2005 |
Funding (selected grants)
2021-2022 |
KIT Future Fields “Screening Platform for Personalized Oncology (SPPO) – Standardized Individual Profiling of Tumours based on Miniaturized Technology for Drug Sensitivity Screening”. |
2021 | HeiKa 2020 “Combining Droplet Microarrays and Mass Spectrometry for Single-Cell Proteomics”. |
2020-2023 | Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg Ideenwettbewerb Biotechnologie |
2020 | HeiKa 2019 “High-throughput compound screening in 3D glioma tumorsphere models”. |
2018-2020 | DFG PO 1820/3-1: “ChIPseq-on-Chip: Droplet-Microarray as a miniaturized high throughput platform for parallel ChIP-seq experiments”. |
2018 | HeiKa 2017 “Eradicating integrin-mediated resistance to the cancer therapies by combinatorial screening in 3D using miniaturized Droplet-Microarrays”. |
Innovation
- Cofounder of Aquarray GmbH, founded 29.03.2018, development and commerciallization of the novel miniaturized platform for cell experiments and personalized medicine.
Awards
- Poster Prize, EMBL/Stanford Personalized Health Conference 2015
- The Tony B. Award, The SLAS Academic Travel Awards Program, SLAS2016
- Nominated for SLAS Innovation Award, SLAS 2016
- The Tony B. Award, The SLAS Academic Travel Awards Program, SLAS2018
- The Tony B. Award, The SLAS Academic Travel Awards Program, SLAS2019